中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
14期
26-27
,共2页
2 型糖尿病%抗凝血酶Ⅲ%凝血酶时间
2 型糖尿病%抗凝血酶Ⅲ%凝血酶時間
2 형당뇨병%항응혈매Ⅲ%응혈매시간
Type 2 diabets%Anti-thrombin Ⅲ%Thrombin time
目的探讨凝血指标中 AT-Ⅲ、TT 变化在糖尿病及其并发症中的临床意义。方法用 Sysmex CA7000全自动凝血分析仪检测2型糖尿病患者和正常人血浆中抗凝血酶 III（AT-III）、凝血酶时间（TT）。结果2型糖尿病患者体内存在着高凝倾向，其血浆中 AT-Ⅲ低于健康对照组（P ＜0.05），而 TT 指标明显比健康对照组延长（P ＜0.01）。结论检测糖尿病患者 AT-Ⅲ、TT，可了解糖尿病微血管病变与凝血活化状态与血栓形成状况之间的关系，为糖尿病的疗效和预后提供依据。
目的探討凝血指標中 AT-Ⅲ、TT 變化在糖尿病及其併髮癥中的臨床意義。方法用 Sysmex CA7000全自動凝血分析儀檢測2型糖尿病患者和正常人血漿中抗凝血酶 III（AT-III）、凝血酶時間（TT）。結果2型糖尿病患者體內存在著高凝傾嚮，其血漿中 AT-Ⅲ低于健康對照組（P ＜0.05），而 TT 指標明顯比健康對照組延長（P ＜0.01）。結論檢測糖尿病患者 AT-Ⅲ、TT，可瞭解糖尿病微血管病變與凝血活化狀態與血栓形成狀況之間的關繫，為糖尿病的療效和預後提供依據。
목적탐토응혈지표중 AT-Ⅲ、TT 변화재당뇨병급기병발증중적림상의의。방법용 Sysmex CA7000전자동응혈분석의검측2형당뇨병환자화정상인혈장중항응혈매 III（AT-III）、응혈매시간（TT）。결과2형당뇨병환자체내존재착고응경향，기혈장중 AT-Ⅲ저우건강대조조（P ＜0.05），이 TT 지표명현비건강대조조연장（P ＜0.01）。결론검측당뇨병환자 AT-Ⅲ、TT，가료해당뇨병미혈관병변여응혈활화상태여혈전형성상황지간적관계，위당뇨병적료효화예후제공의거。
Objective To detect the clinical values of anti-thrombin Ⅲ(AT-Ⅲ) and thrombin time (TT) in patients with type 2 diabete but also in complications. Methods CA7000 was used for detection of type 2 diabetic patients and control group's anti-thrombin Ⅲ(AT-Ⅲ) and thrombin time (TT). Results The patients with type 2 diabete were in hypercoagulable state easily .The AT-Ⅲ in group of type 2 diabetes were significantly lower than that of the normal control one, and TT is significantly longer than the normal control one. Conclusion The detection of AT-III and TT could help clinical doctors to observe the correlation between microangiopathy disease and thrombin activation, which is useful for diagnosis and avoiding the vascular pathological changes .
